Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
0903608 B C Ltd. operates in Biotechnology & Pharmaceuticals and has 3 pending office actions. Those matters involve 3 distinct examiners across 3 art units.
BROWE, DAVID is the busiest examiner, with 1 pending matter. The pending work is distributed across the same number of examiners and art units as matters, indicating no concentration in the available assignment data.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BROWE, DAVID | 1 | 26.8% | +27.8% |
| KUCHARCZK, JED A | 1 | 80.4% | +16.3% |
| BOECKELMAN, JACOB A | 1 | 34.6% | +46.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17281210 | SYNERGISTIC PESTICIDAL COMPOSITIONS FOR DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS THEREFOR | KUCHARCZK, JED A | 14d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17789486 | PESTICIDAL COMPLEX COMPOSITIONS FOR SYNERGISTIC DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS OF SELECTION THEREOF | BROWE, DAVID | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16651084 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | BOECKELMAN, JACOB A | 8d overdue |
| 17281210 | SYNERGISTIC PESTICIDAL COMPOSITIONS FOR DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS THEREFOR | KUCHARCZK, JED A | 14d |
| 17789486 | PESTICIDAL COMPLEX COMPOSITIONS FOR SYNERGISTIC DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS OF SELECTION THEREOF | BROWE, DAVID | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1623 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17789486 | PESTICIDAL COMPLEX COMPOSITIONS FOR SYNERGISTIC DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS OF SELECTION THEREOF | BROWE, DAVID | 1617 | §103§112 | Final Rejection | — | Pending | Jun 27, 2022 |
| 17281210 | SYNERGISTIC PESTICIDAL COMPOSITIONS FOR DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS THEREFOR | KUCHARCZK, JED A | 1623 | §103 | Final Rejection | 14d | Pending | Mar 29, 2021 |
| 16651084 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | BOECKELMAN, JACOB A | 1655 | §103DP | Final Rejection | 8d overdue | Pending | Mar 26, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial0903608 B C Ltd. has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.
David Browe has the most, with 1 of 0903608 B C Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.